Skip to main content
logo
Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
8.82
+0.16 (1.85%)
At close: Oct 8, 2026, 4:00 PM EDT
8.65
-0.17 (-1.93%)
After-hours: Oct 8, 2026, 4:10 PM EDT

Vicore Pharma Holding AB Revenue

Vicore Pharma Holding AB had revenue of 2.21M SEK in the quarter ending June 30, 2026, with 26.75% growth. This brings the company's revenue in the last twelve months to 3.99M, down -48.40% year-over-year. In the year 2025, Vicore Pharma Holding AB had annual revenue of 3.82M, down -96.51%.

Revenue (ttm)
3.99M SEK
Revenue Growth
-48.40%
P/S Ratio
594.24
Revenue / Employee
86,826 SEK
Employees
46
Market Cap
244.88M USD

Revenue Chart

Chart
* This company reports financials in SEK.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.82M-105.53M-96.51%
Dec 31, 2024109.35M--
Dec 31, 20230--
Dec 31, 20220--
Dec 31, 20210--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 2018508.00K-424.00K-45.49%
Dec 31, 2017932.00K80.00K9.39%
Dec 31, 2016852.00K12.00K1.43%
Dec 31, 2015840.00K-11.00K-1.29%
Dec 31, 2014851.00K131.00K18.19%
Dec 31, 2013720.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Bicycle Therapeutics61.21M
Q32 Bio53.74M
Zentalis Pharmaceuticals26.87M
AC Immune21.67M
Pyxis Oncology11.04M
Camp4 Therapeutics4.22M
Upstream Bio3.16M
Sol-Gel Technologies1.80M
Revenue Rankings

VCRE News

More News